DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Murthy RK, Loi S, Okines A. et al.
Tucatinib, trastuzumab and capecitabine for HER2-positive metastatic breast cancer.
N Engl J Med 2020;
382: 597-609
DOI: 10.1056/NEJMoa1914609.
We do not assume any responsibility for the contents of the web pages of other providers.